Skip to content

Resilience Through Interventions for Successful Early Outcomes

Leveraging Scientific Advances to Strengthen the Implementation, Evaluation, and Impacts of Intervention Programs for Children Experiencing Early Life Adversity

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06669624
Acronym
RISE
Enrollment
150
Registered
2024-11-01
Start date
2024-11-12
Completion date
2027-08-01
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Caregiver Child Relationship, Child Behavior Problem, Mental Health, Parenting Intervention, Stress

Keywords

Attachment and Biobehavioral CatchUp, Parenting Intervention, RISE study, Child behavior, Biomarkers

Brief summary

Purpose: The purpose of this research is to determine the effects of Attachment and Biobehavioral Catch-up (ABC), an evidence-based parenting program, on stress biomarkers in children. Participants: The study will involve approximately 150 caregiver-child dyads, with children aged between 24 and 42 months. Participants will include primary caregivers fluent in English or Spanish, along with their children who have experienced social risk factors for adversity. Procedures (Methods): Participants will be randomly assigned to either receive the ABC parenting program (10 sessions) immediately or be placed on a wait-list, receiving the program after about 4 months. The study procedures include caregivers completing online surveys, engaging in play-based observational tasks with their children, and collecting non-invasive biological samples (saliva, cheek swab, hair) from the children and saliva samples from the caregivers at 2-3 time-points.

Interventions

10-session home visiting intervention designed to increase parental sensitivity and nurturance and decrease parental frightening behavior.

OTHERWaitlist with 4-month delay, then ABC

A 4-month waitlist period, after which they will also receive the home-based ABC program (same as Intervention group).

Sponsors

University of North Carolina, Chapel Hill
Lead SponsorOTHER
University of California, San Francisco
CollaboratorOTHER
The Duke Endowment
CollaboratorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
TRIPLE (Caregiver, Investigator, Outcomes Assessor)

Intervention model description

RCT with a waitlist control group

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Parent/Caregiver Inclusion Criteria : * Aged 18 or older * Speaks English or Spanish * Is the parent or legal guardian with legal custody of a child aged between 24 months and 42 months * Is a primary caregiver/parent * Has a home-like environment in which to participate in the intervention Child Inclusion Criteria: * Aged between 24 months and 42 months at enrollment * Lives with the parent/caregiver at least 50% of the time * Has experienced social risk factors, including low income, community or family violence, previous trauma/adversity exposure, prolonged separation from caregiver, significant difficulties in relationship with caregiver Child

Exclusion criteria

* Has a diagnosed genetic or congenital disorders, including but not limited to Down syndrome, cerebral palsy, seizure disorders, endocrine disorders (or is using steroid medications, including human growth hormone), or was born with birth defects

Design outcomes

Primary

MeasureTime frameDescription
Child inflammationPre-intervention baselinePediatric saliva samples will be assayed for cytokine concentrations.
Child epigenetic age accelerationPre-intervention baselinePediatric buccal swabs will be assayed for DNAm, which will be used to calculate child epigenetic age
Child telomere lengthPre-intervention baselineDNA will be extracted from child buccal swabs to calculated T/S ratios.
Child hair cortisolPre-intervention baselineSeveral strands of hair will be collected and assayed to obtain hair cortisol concentration
Child stress hormonesPre-intervention baselineChild hair and saliva samples for cortisol, cortisone, DHEA, progesterone, and endocannabinoid levels to examine both cumulative and dynamic stress hormone responses.
ParentingPre-intervention baselineBehavioral coding of parenting will be conducted using video recordings of tasks from the Early Regulation in Context Assessment.
Child wellbeingPre-intervention baselineCaregiver reports of their child's quality of life will be obtained using the Pediatric Quality of Life (PedsQL) Inventory. Scores range from 0 to 100, with higher scores indicating better functioning.
Child executive functioningPre-intervention baselineChild executive functioning will be assessed using the Minnesota Executive Function Scale™ The MEFS has been nationally normed based on the child's age and standardized scores are automatically generated using an algorithm that combines accuracy and response time (M = 100, SD = 15). Scores range from 60-140, with higher scores indicating better performance.
Child mental healthPre-intervention baselineChild mental health will be assessed using caregiver reports through the Child Behavior Checklist preschool-aged form (1.5-5). We will use the total, internalizing, and externalizing subscales, with scores ranging from 0-200, 0-72, and 0-48, respectively. Higher scores represent worse functioning.
Caregiver anxietyPre-intervention baselineCaregiver anxiety symptoms will be assessed using the Generalized Anxiety Disorder 7-item (GAD-7) scale. The total score ranges from 0-21, with higher scores indicating more severe anxiety.
Caregiver depressionPre-intervention baselineCaregiver depression symptoms will be assessed using the Patient Health Questionnaire-9 item form. Scores range from 0 to 27, with higher scores representing worse functioning.

Countries

United States

Contacts

CONTACTDanielle Rouvinov, PhD
roubinov@email.unc.edu919-843-5898
CONTACTNicole Bush, PhD
Nicole.Bush@ucsf.edu415-476-7655
PRINCIPAL_INVESTIGATORDanielle Roubinov, PhD

University of North Carolina, Chapel Hill

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026